Thymosin Alpha-1 3 mg

Technical Details

Dosage & Usage Guidelines

In most preclinical studies, researchers use Thymosin Alpha-1 at dosages of 1–3 mg per week, typically administered subcutaneously. The peptide has a relatively short half-life (~2 hours), making multiple low-dose administrations common depending on the duration of the study (e.g., 2–4 weeks).

Stacking Suggestions

Thymosin Alpha-1 is often stacked with other immune-regulating or regenerative peptides for comprehensive system support:

• Thymalin – for thymic regeneration and T-cell development
• Selank – for neuroimmune balance and cognitive focus
• AOD 9604 – supports metabolic health and immune-linked fat metabolism
• BPC-157 – promotes healing in tissues and gut mucosa
• SS-31 – for mitochondrial protection and cellular repair

Safety and Laboratory Observations

Thymosin Alpha-1 has demonstrated a strong safety profile in animal models and early-phase human trials. It does not interact with hormonal systems and poses no liver or kidney toxicity. Injection site reactions may occur but are generally mild and transient. It is not approved by the FDA for clinical use and is designated for research purposes only.

USA Domestic Shipping and Product Quality

All Peptide Hubs products, including Thymosin Alpha-1 3 mg, are eligible for USA domestic shipping with fast, discreet delivery. Each vial is manufactured in GMP-compliant labs and tested for purity. Consider pairing with GHK-Cu or CJC-1295 DAC for systemic immune and regenerative research protocols.

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA Domestic shipping is typically faster when local stock is selected
• ✔ International orders include tracking, though update frequency may vary by destination
• ✔ Multiple warehouses may result in separate shipments when applicable

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.

After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions